Comparison

Sulfamethoxazole European Partner

Item no. HY-B0322-10g
Manufacturer MedChem Express
CASRN 723-46-6
Amount 10 g
Category
Type Inhibitors
Specific against other
Purity 99.91
Citations [1]Zambuzzi-Carvalho et al. Transcriptional profile of the human pathogenic fungus Paracoccidioides lutzii in response to sulfamethoxazole. Med Mycol. 2015;53(5):477-492. |[2]Choonara BF, et al. A menthol-based solid dispersion technique for enhanced solubility and dissolution of sulfamethoxazole from an oral tablet matrix. AAPS PharmSciTech. 2015 Aug;16(4):771-86.|[3]Ogata H, et al. Dose Dependent Effect of Sulfamethoxazole on Inhibiting KATP Channel of Mouse Pancreatic β Cell. Dose Response. 2023 Sep 28;21(3):15593258231203611.
ACS Environ Au. 2025 Aug 8.
Anal Chem. 2025 Jun 3;97(21):11099-11109.
Autophagy. 2023 Oct;19(10):2702-2718.
Bioresour Technol Rep. 2023 Dec, 24, 101619.
bioRxiv. 2024 May 10.
bioRxiv. 2025 January 19.
Chemosphere. 2019 Jun:225:378-387.
Clean Technol Environ Policy. 2025 May 22.
Clin Chem. 2019 Dec;65(12):1522-1531.
Ecotoxicol Environ Saf. 2023 Mar 15:253:114711.
Eur J Clin Microbiol Infect Dis. 2025 Sep 29.
Microorganisms. 2025 Apr 18;13(4):938.
Pharmaceutics. 2025 Mar 26;17(4):423.
Signal Transduct Target Ther. 2023 Sep 18;8(1):353.
Water Res. 2023 Jul 15:240:120110.
Water. 2025 Jun 6.
Nat Commun. 2022 Mar 2;13(1):1116.
Smiles O=S(C1=CC=C(N)C=C1)(NC2=NOC(C)=C2)=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Ro 4-2130
Shipping Condition Room temperature
Available
Manufacturer - Type
Reference compound1
Manufacturer - Applications
COVID-19-immunoregulation
Manufacturer - Category
Reference compound / Active compounds; API
Manufacturer - HS Code
H303, H317, H361
Shipping Temperature
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Description
Sulfamethoxazole (Ro 4-2130) is a sulfonamide antibiotic with a widespread antibacterial activity. Sulfamethoxazole inhibits bacterial folate metabolism by competing with 4-Aminobenzoic acid (HY-B1008) (PABA) to act on dihydropteroate synthetase and dihydropteroate reductase. Sulfamethoxazole can be used for the study of urinary tract infections (UTIs), prostatitis, and bronchitis[1][2][3].
Manufacturer - Research Area
Infection; Cancer
Solubility
DMSO : ≥ 100 mg/mL|H2O : < 0.1 mg/mL
Manufacturer - Pathway
Anti-infection
Clinical information
Launched
UNSPSC Code
12352005
Precautionary
H303, H317, H361

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 g
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?